(Reuters) - The company, which in June said Chief Executive Robert
Jelenic would take a leave of absence to undergo treatment for
cancer, posted net income of $5.5 million, or 14 cents a share,
down from $9.8 million, or 25 cents a share, a year earlier.
Excluding an adverse tax adjustment resulting from a change
in New York state law, the company said profit was 17 cents a
share.
Read more at Reuters.com Market News
Jelenic would take a leave of absence to undergo treatment for
cancer, posted net income of $5.5 million, or 14 cents a share,
down from $9.8 million, or 25 cents a share, a year earlier.
Excluding an adverse tax adjustment resulting from a change
in New York state law, the company said profit was 17 cents a
share.
Read more at Reuters.com Market News
No comments:
Post a Comment